Document Type
Conference Proceeding
Publication Date
11-17-2024
Publication Title
Cancer Research
Abstract
Introduction Obesity is associated with an increased risk of developing renal cell carcinoma (RCC) but paradoxically correlates with improved outcomes in metastatic cases. Moreover, the data on the relationship between obesity and postoperative outcomes following nephrectomy are inconsistent. Accurate prediction of postoperative outcomes, including complications, 30-day readmissions, and mortality, is essential for improving patient outcomes in surgical procedures. In this study, we utilized ML models to predict such outcomes in RCC patients undergoing nephroureterectomy, radical nephrectomy, partial nephrectomy, and other excision procedures on the kidney using data from the National Surgical Quality Improvement Program (NSQIP; 2016- 2021). Methods A gradient-boosted tree (GBT) ML model was developed and trained to predict the primary outcomes of interest: major complications, minor complications, 30-day readmission, and mortality. Patients with a BMI ≥30 kg/m2 were considered obese, and patients with a BMI /m2 were used as controls. The model's performance was rigorously evaluated using various measures, such as AUROC, generalized R-square, and misclassification rate. The model's predictions were validated using separate training (70%) and validation (30%) cohorts to ensure generalizability and applicability in diverse patient populations. Results In the analysis, 36,284 cases were included. Bivariate analysis revealed that obesity was associated with an increased rate of minor complications (5.48% vs. 4.41%, p
Volume
84
Issue
22_Supplement
First Page
A026
Recommended Citation
Khosla AA, Pustake M, Chhabra S, Zhang Y, Roy M, Rubens M et al [Jaiyesimi I] Assessing the impact of obesity on postoperative outcomes in RCC using machine learning. Cancer Res. 2024 Nov; 84(Suppl 22): A026.doi: 10.1158/1538-7445.TUMBODY-A026
DOI
10.1158/1538-7445.TUMBODY-A026
Included in
Hematology Commons, Internal Medicine Commons, Oncology Commons
Comments
AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer. November 17-20, 2024, Boston, Massachusetts